A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

Clinical trial NCT05513586 · COMPLETED

Trial details

NCT number: NCT05513586
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases (PID)

Start date: 2022-09-13
Primary completion: 2025-10-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.